✦ LIBER ✦

Evaluation of safety and clinical activity of multiple doses of the anti-CD80 monoclonal antibody, galiximab, in patients with moderate to severe plaque psoriasis

✍ Scribed by Alice B Gottlieb; Sewon Kang; Kenneth G Linden; Mark Lebwohl; Alan Menter; Ahsan A Abdulghani; Michael Goldfarb; Nicole Chieffo; Mark C Totoritis

Book ID: 116366146
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 343 KB
Volume: 111
Category: Article
ISSN: 1090-2341
DOI: 10.1016/j.clim.2004.01.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical and histologic response to sing

Clinical and histologic response to single-dose treatment of moderate to severe psoriasis with an anti-CD80 monoclonal antibody

✍ Alice B. Gottlieb; Mark Lebwohl; Mark C. Totoritis; Ahsan A. Abdulghani; Steve R 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 299 KB

The safety of efalizumab in patients wit

The safety of efalizumab in patients with moderate to severe plaque psoriasis: summary of clinical trial experience

✍ Craig Leonardi; Bernard Goffe; Jeff Sobell; Ivor Caro 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Efficacy and safety of itolizumab, a nov

Efficacy and safety of itolizumab, a novel anti-CD6 monoclonal antibody, in patients with moderate to severe chronic plaque psoriasis: Results of a double-blind, randomized, placebo-controlled, phase-III study

✍ Krupashankar, D.S.; Dogra, Sunil; Kura, Mahendra; Saraswat, Abir; Budamakuntla, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 694 KB

A multiple dose randomized double-blind

A multiple dose randomized double-blind placebo-controlled study to determine the efficacy and safety of a humanized anti-CD4 monoclonal antibody in the treatment of moderate to severe chronic psoriasis vulgaris

✍ Gottlieb, AB; Krueger, J; Lebwohl, M; Gisoldi, E; Grossman, RM; Wacholtz, MC 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 190 KB

A randomized study to evaluate the effic

A randomized study to evaluate the efficacy and safety of adding topical therapy to etanercept in patients with moderate to severe plaque psoriasis

✍ Lebwohl, Mark G.; Kircik, Leon; Callis Duffin, Kristina; Pariser, David; Hooper, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 561 KB

Safety and Efficacy of ABT-874, a Fully

Safety and Efficacy of ABT-874, a Fully Human Interleukin 12/23 Monoclonal Antibody, in the Treatment of Moderate to Severe Chronic Plaque Psoriasis

✍ Kimball, Alexa B. 📂 Article 📅 2008 🏛 American Medical Association 🌐 English ⚖ 157 KB